Grifols SA

OZTA

Company Profile

  • Business description

    Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

  • Contact

    Avinguda de la Generalitat, 152-158
    Parc de Negocis Can Sant Joan
    Sant Cugat del Valles
    Barcelona08174
    ESP

    T: +34 935710500

    E: [email protected]

    https://www.grifols.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2026

    Employees

    25,247

Stocks News & Analysis

stocks

Avoid these overvalued ASX shares

The two shares with the highest price to fair value in our Australian coverage.
stocks

Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?

Watching AI monetization, capex’s impact on margins, and guidance on Azure.
stocks

Lithium’s latest drop and what it means for ASX investors

Volatility returns to the lithium market.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,004.9014.700.16%
CAC 408,437.8974.750.89%
DAX 4025,155.41144.060.58%
Dow JONES (US)52,290.4765.830.13%
FTSE 10010,716.97131.061.24%
HKSE24,892.66239.63-0.95%
NASDAQ25,740.3096.91-0.38%
Nikkei 22566,115.60116.59-0.18%
NZX 50 Index13,763.18107.150.78%
S&P 5007,507.841.36-0.02%
S&P/ASX 2008,823.0016.500.19%
SSE Composite Index3,867.032.670.07%

Market Movers